Abstract

ICL Group will report its second-quarter 2026 results on August 5, 2026 Pre-Market; this preview synthesizes last quarter’s performance, the latest market expectations for adjusted EPS and key margins, and the factors most likely to shape the stock’s near-term reaction.

Market Forecast

Consensus currently centers on adjusted EPS of 0.107 US dollars for the second quarter of 2026, implying year-over-year growth of 32.30%; formal forecasts for revenue, gross profit margin, and net profit margin are not disclosed in the available datasets, so we focus on EPS while using last quarter’s mix as the operating baseline. Based on last quarter’s revenue composition, the business remains anchored by Phosphate Solutions and Potash, with Growing Solutions providing a higher-value contribution; revenue mix stability and operating leverage are expected to be the key swing variables for margins in the upcoming print. Growing Solutions is positioned as the most promising contributor within the portfolio after delivering 551.00 million US dollars last quarter, supported by a product mix that typically benefits from seasonal sell-through and cross-portfolio commercialization of specialty offerings.

Last Quarter Review

ICL Group posted revenue of 2.02 billion US dollars in the prior quarter, with a gross profit margin of 30.94%, GAAP net profit attributable to shareholders of 126.00 million US dollars, a net profit margin of 6.23%, and adjusted EPS of 0.11 US dollars, up 22.22% year over year. Quarter-on-quarter, net profit accelerated by 272.60%, underscoring a pronounced improvement in profit conversion relative to the preceding period. Within the revenue mix, Phosphate Solutions contributed 679.00 million US dollars, Growing Solutions delivered 551.00 million US dollars, Potash generated 503.00 million US dollars, and Industrial Products added 349.00 million US dollars; total company revenue increased 14.49% year over year, with growth supported by a recovery from the prior-year base and favorable segment mix.

Current Quarter Outlook

Phosphate Solutions and Potash: Margin sensitivity and volume mix

The upcoming quarter will likely hinge on how revenue mix and realized pricing translate into margins against the 30.94% gross margin baseline from last quarter. Management’s operational execution in the prior quarter translated into a 6.23% net profit margin and 126.00 million US dollars of net profit, with a 272.60% quarter-on-quarter expansion in net income highlighting the degree of operating leverage as volumes and mix normalized. A repeatable path to sustaining or modestly expanding gross margins would likely require maintaining realized prices close to last quarter’s levels while securing incremental contribution from higher-margin phosphate derivatives and specialty products embedded in the Phosphate Solutions suite.

From a volume standpoint, sequential dynamics can introduce variance: second-quarter shipments typically coincide with strong in-season demand channels for crop-nutrition and industrial end markets, while logistics timing and customer inventory preferences can shift revenue recognition within the half. Any incremental lift in volumes at stable pricing should provide favorable fixed-cost absorption, supporting a gross-margin hold or slight expansion; conversely, any discounting or weaker mix would pressure unit margins more quickly than revenue. The net impact on earnings sensitivity is high, considering that last quarter’s margin baseline leaves room for expansion if mix improves even modestly.

For Potash, unit economics are sensitive to realized prices and freight. Last quarter’s contribution of 503.00 million US dollars anchors the segment’s scale contribution to consolidated revenue. Should volumes track seasonal patterns with stable netbacks, the segment could contribute to preserving consolidated margins near the last quarter’s level; if realized prices slip or freight costs rise, the drag would likely appear in consolidated gross margin before operating expense offsets can materialize. The market’s EPS expectation of 0.107 US dollars implicitly assumes that any price-volume noise in Potash will be contained by mix benefits elsewhere and disciplined cost execution.

Growing Solutions: Specialty contribution and earnings quality

Growing Solutions supplied 551.00 million US dollars last quarter and remains a focal point for higher-value, specialty-driven revenue. The quality of earnings here matters. Specialty formulations and higher-value product lines tend to support structurally higher gross margins and steadier pricing; when these offerings scale, they can buffer consolidated gross margin against fluctuations in bulk-oriented chains. If the second quarter sees continued sell-through of premium products, along with solid order replenishment, the segment can add incremental points to consolidated gross margin versus the last quarter’s 30.94% benchmark.

The second quarter often aligns with the heaviest application windows in several end-user markets and historically benefits from restocking patterns. Translating that seasonality into earnings requires clean execution: on-time fulfillment, tight working-capital control to convert revenue into cash, and maintaining pricing discipline across geographies. Given the EPS consensus of 0.107 US dollars and a year-over-year growth implication of 32.30%, the market appears to be underwriting a constructive contribution from Growing Solutions without relying on aggressive price or volume assumptions. The degree to which this segment’s product mix expands relative to bulk businesses will likely determine whether consolidated net margin can hold near or improve from the prior quarter’s 6.23%.

Investors may also watch product introduction cadence and cross-selling momentum, which influence both realized pricing and shipment timing. If mix skews toward more value-added solutions, the revenue-to-gross-profit conversion ratio should improve, enhancing operating leverage into EPS. A flat or less favorable mix would leave EPS more dependent on volume and cost controls elsewhere.

Stock-price swing factors this quarter

The first and most visible swing factor is the headline EPS relative to the 0.107 US dollars expectation and the accompanying trajectory of gross margin against the prior quarter’s 30.94%. A modest beat on EPS with stable or improving gross margins is likely to be interpreted as evidence that the specialty mix is scaling and that the earnings base is normalizing after last year’s trough. Conversely, an EPS miss driven by weaker margins would raise questions about pricing discipline, product mix, and cost pressure timing.

Revenue composition versus last quarter’s 2.02 billion US dollars matters as well. The Street will scrutinize whether Phosphate Solutions and Growing Solutions sustain or expand their combined share of sales, since those segments have been pivotal in balancing profitability. A revenue outcome that is broadly stable while preserving mix quality can still deliver an EPS outcome near the 0.107 US dollars marker, given the sensitivity of margins to mix and fixed-cost leverage. On the other hand, a heavier tilt toward lower-margin shipments would likely compress gross profit dollars more than top-line suggests.

The second swing factor lies in cash generation and capital structure. Following the new senior notes offering announcement in early June, the market will watch for updates on financing terms, debt maturity ladder, and cost of capital. Clean conversion of earnings to cash through the quarter—via disciplined receivables and inventory management—would alleviate concerns about working capital intensity in the seasonal peak. Clear commentary on capital allocation, including dividend cadence and discretionary growth spending, can also affect post-print sentiment, especially if the company demonstrates the ability to fund growth while preserving balance-sheet flexibility.

The third swing factor is guidance detail. Any specificity around the back half trajectory for margins, volume seasonality, or pricing parameters would likely overshadow small variances in the second-quarter print itself. If management reiterates discipline on costs and provides a path for margin resilience with a stable to improving specialty mix, the market’s comfort with the EPS baseline should improve. If commentary signals increased variability in prices or a softer mix, the stock could react to a change in perceived earnings quality rather than the point-in-time print.

Analyst Opinions

Bullish opinions currently hold the majority versus bearish within the collected set for the period from January 1, 2026 to July 29, 2026, supported by positive institutional stances and a constructive view on near-term earnings normalization. On May 11, 2026, S&P reaffirmed ICL Group’s long-term issuer rating at BBB- with a stable outlook, while separate commentary in early June highlighted that the company maintains BBB- ratings with stable outlooks from both S&P and Fitch as it launched a new senior notes offering. These credit assessments signal institutional confidence in the company’s balance sheet resilience and liquidity management, which feed into a constructive bias on equity risk, particularly when combined with signs of earnings recovery.

From an earnings point of view, the prior quarter’s adjusted EPS of 0.11 US dollars exceeded market expectations and came alongside a 22.22% year-over-year increase, which investors typically view as confirmation that operating discipline and product mix are improving. For the upcoming quarter, the current 0.107 US dollars adjusted EPS expectation with a 32.30% implied year-over-year growth profile suggests that analysts and institutions anticipate continuity in that recovery rather than a reversal. In practice, this embeds modest assumptions for margins and volume, which, if met or exceeded, could reinforce the bullish stance predicated on normalization.

The bullish argument centers on three points. First, last quarter’s 30.94% gross margin and 6.23% net profit margin offer a firmer base than seen in the prior year; sustaining those margins while keeping revenue broadly stable near last quarter’s 2.02 billion US dollars would be sufficient to deliver the forecasted EPS. Second, the revenue composition remains favorable to earnings quality: Phosphate Solutions and Growing Solutions together contributed 1.23 billion US dollars last quarter, cushioning volatility in bulk-oriented lines and enhancing mix. Third, institutional validation via stable investment-grade ratings supports access to funding for working capital and growth initiatives, reducing downside risk to the earnings trajectory in peak seasonal quarters.

Within this framework, bullish institutions will focus on whether the company translates seasonal volume into margin-accretive sales, reveals tight operating cost control, and affirms a prudent capital plan. A beat on EPS or a clean hold with stable gross margins would likely extend the recent narrative of normalized profitability. Conversely, a miss caused by mix slippage or weaker margins would not necessarily overturn the constructive medium view if management’s guidance provides credible levers for the back half. The current setup, as reflected by the balance of institutional commentary in the period, favors the optimistic case that the second quarter can deliver on the 0.107 US dollars adjusted EPS baseline with supportive margin and mix dynamics.